{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:22:43Z","timestamp":1785298963303,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,5,31]],"date-time":"2014-05-31T00:00:00Z","timestamp":1401494400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00296-014-3054-7","type":"journal-article","created":{"date-parts":[[2014,5,30]],"date-time":"2014-05-30T03:55:27Z","timestamp":1401422127000},"page":"183-188","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Intraorbital injection of Rituximab in idiopathic orbital inflammatory syndrome: case reports"],"prefix":"10.1007","volume":"35","author":[{"given":"Gustavo","family":"Savino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remo","family":"Battendieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Siniscalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Mandar\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Mul\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Petrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Traina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Riso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,31]]},"reference":[{"key":"3054_CR1","first-page":"127","volume":"32","author":"A Birch-Hirschfeld","year":"1905","unstructured":"Birch-Hirschfeld A (1905) Zur diagnostic ant pathologic der orbital tumoren. Ber Zusammenkunft Dtsch Ophthalmol Ges 32:127\u2013135","journal-title":"Ber Zusammenkunft Dtsch Ophthalmol Ges"},{"key":"3054_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1076\/ocii.11.1.3.15577","volume":"11","author":"LK Gordon","year":"2003","unstructured":"Gordon LK (2003) Diagnostic dilemmas in orbital inflammatory disease. Ocul Immunol Inflamm 11:3\u201315","journal-title":"Ocul Immunol Inflamm"},{"key":"3054_CR3","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ophtha.2003.01.002","volume":"111","author":"JA Shields","year":"2004","unstructured":"Shields JA, Shields CL, Scartozzi R (2004) Survey of 1264 patients with orbital tumor and simulating lesions: the 2002 Montgomery Lecture, part 1. Ophthalmology 111:997\u20131008","journal-title":"Ophthalmology"},{"key":"3054_CR4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/000348948909800702","volume":"98","author":"MC Weissler","year":"1989","unstructured":"Weissler MC, Miller E, Fortune MA (1989) Sclerosing orbital pseudotumor: a unique clinicopathologic entity. Ann Otol Rhinol Laryngol 98:496\u2013501","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"3054_CR5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0161-6420(96)30663-5","volume":"103","author":"I Mombaerts","year":"1996","unstructured":"Mombaerts I, Schlingemann RO, Goldschmeding R, Koorneeef L (1996) Are systemic corticosteroids useful in the management of orbital pseudotumors? Ophthalmology 103:521\u2013528","journal-title":"Ophthalmology"},{"key":"3054_CR6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/archophthalmol.2011.16","volume":"129","author":"J Plaza","year":"2011","unstructured":"Plaza J, Garrity J, Dogan A, Amanthamurthy A, Witzing T, Salomao D (2011) Orbital inflammation with IgG4-positive plasma cells; manifestations of IgG4 systemic disease. Arch Ophthalmol 129:421\u2013428","journal-title":"Arch Ophthalmol"},{"key":"3054_CR7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.survophthal.2011.07.004","volume":"57","author":"ZS Wallace","year":"2012","unstructured":"Wallace ZS, Khosroshahi A, Jakobiec FA, Deshpande V, Hatton MP, Ritter J, Ferry JA, Stone JH (2012) IgG4-related Systemic disease as a cause of \u201cidiopathic\u201d orbital inflammation, including orbital myositis, and trigeminal nerve involvement. Surv Ophthalmol 57:26\u201333","journal-title":"Surv Ophthalmol"},{"key":"3054_CR8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/IOP.0b013e31823d2103","volume":"28","author":"BJ Winn","year":"2012","unstructured":"Winn BJ, Rootman J (2012) Sclerosing orbital inflammation and systemic disease. Ophthal Plast Reconstr Surg 28:107\u2013118","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"3054_CR9","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/eye.2012.4","volume":"26","author":"D Lindfield","year":"2012","unstructured":"Lindfield D, Attfield K, McElvanney A (2012) Systemic immunoglobulin G4 (IgG4) disease and idiopathic orbital inflammation; removing \u2018idiopathic\u2019 from the nomenclature? Eye 26:623\u2013629","journal-title":"Eye"},{"key":"3054_CR10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/ICU.0b013e32835563ec","volume":"23","author":"A Berry-Brincat","year":"2012","unstructured":"Berry-Brincat A, Rose GE (2012) Idiopathic orbital inflammation: a new dimension with the discovery of immunoglobulin G4-related disease. Curr Opin Ophthalmol 23:415\u2013419","journal-title":"Curr Opin Ophthalmol"},{"key":"3054_CR11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1148\/radiology.173.2.2678252","volume":"173","author":"CK Maves","year":"1989","unstructured":"Maves CK, Johnson JF, Bove K, Malott RL (1989) Gastric inflammatory pseudotumor in children. Radiology 173:381\u2013383","journal-title":"Radiology"},{"key":"3054_CR12","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1148\/rg.233025073","volume":"23","author":"LD Narla","year":"2003","unstructured":"Narla LD, Newman B, Spottswood SS, Narla S, Kolli R (2003) Inflammatory pseudotumor. Radiographics 23:719\u2013729","journal-title":"Radiographics"},{"key":"3054_CR13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2214\/AJR.11.7288","volume":"198","author":"M Patnana","year":"2012","unstructured":"Patnana M, Sevrukov AB, Elsayes KM, Viswanathan C, Lubner M, Menias CO (2012) Inflammatory pseudotumor: the great mimicker. Am J Roentgenol 198:217\u2013227","journal-title":"Am J Roentgenol"},{"key":"3054_CR14","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/bjophthalmol-2012-302926","volume":"97","author":"WR Bijlsma","year":"2013","unstructured":"Bijlsma WR, Kalmann R, Dekkers J, Paridaens D, Mourits MP, Kloos R, de Groot-Mijnes JD (2013) Identification of infectious entities in idiopathic orbital inflammation biopsies. Br J Ophthalmol 97:664\u2013665","journal-title":"Br J Ophthalmol"},{"key":"3054_CR15","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/jcp.26.9.639","volume":"26","author":"A Garner","year":"1973","unstructured":"Garner A (1973) Pathology of \u201cpseudotumours\u201d of the orbit: a review. J Clin Pathol 26:639\u2013648","journal-title":"J Clin Pathol"},{"key":"3054_CR16","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/bjo.2007.124156","volume":"91","author":"BN Swamy","year":"2007","unstructured":"Swamy BN, McCluskey P, Nemet A, Crouch R, Martin P, Benger R, Ghabriel R, Wakefield D (2007) Idiopathic orbital inflammatory syndrome: clinical features and treatment outcomes. Br J Ophthalmol 91:1667\u20131670","journal-title":"Br J Ophthalmol"},{"key":"3054_CR17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s11926-010-0128-8","volume":"12","author":"GM Espinoza","year":"2010","unstructured":"Espinoza GM (2010) Orbital inflammatory pseudotumors: etiology, differential diagnosis, and management. Curr Rheumatol Rep 12:443\u2013447","journal-title":"Curr Rheumatol Rep"},{"key":"3054_CR18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/archopht.121.4.491","volume":"121","author":"SJ Yuen","year":"2003","unstructured":"Yuen SJ, Rubin PA (2003) Idiopathic orbital inflammation: distribution, clinical features and treatment outcome. Arch Ophthalmol 121:491\u2013499","journal-title":"Arch Ophthalmol"},{"key":"3054_CR19","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00055735-200212000-00001","volume":"13","author":"D Jacobs","year":"2002","unstructured":"Jacobs D, Galletta S (2002) Diagnosis and management of orbital pseudotumor. Curr Opin Ophthalmol 13:347\u2013351","journal-title":"Curr Opin Ophthalmol"},{"key":"3054_CR20","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/ICU.0b013e328355715e","volume":"23","author":"BP Carruth","year":"2012","unstructured":"Carruth BP, Wladis EJ (2012) Inflammatory modulators and biologic agents in the treatment of idiopathic orbital inflammation. Curr Opin Ophthamol 23:420\u2013426","journal-title":"Curr Opin Ophthamol"},{"key":"3054_CR21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1399-0039.2007.00863.x","volume":"70","author":"VH Ho","year":"2007","unstructured":"Ho VH, Chevez-Barrios P, Jorgesen JL, Silkiss RZ, Esmaeli B (2007) Receptor expression in orbital inflammatory syndromes and implications for targeted therapy. Tissue Antigens 70:105\u2013109","journal-title":"Tissue Antigens"},{"key":"3054_CR22","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.leukres.2011.01.030","volume":"35","author":"L Laurenti","year":"2011","unstructured":"Laurenti L, De Padua L, Battendieri R, Tarnani M, Sica S, Blasi MA, Savino G, Leone G (2011) Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluation. Leuk Res 35:682\u2013684","journal-title":"Leuk Res"},{"key":"3054_CR23","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/j.1349-7006.2011.01976.x","volume":"102","author":"G Savino","year":"2011","unstructured":"Savino G, Battendieri R, Balia L, Colucci D, Larocca LM, Laurenti L, De Padua L, Blasi MA, Balestrazzi E (2011) Evaluation of intraorbital injection of rituximab for treatment of primary ocular adnexal lymphoma: a pilot study. Cancer Sci 102:1565\u20131567","journal-title":"Cancer Sci"},{"key":"3054_CR24","first-page":"173","volume":"38","author":"G Savino","year":"2013","unstructured":"Savino G, Balia L, Colucci D, Battendieri R, Gari M, Corsello SM, Pontecorvi A, Dickmann A (2013) Intraorbital injection of rituximab: a new approach for active thyroid-associated orbitopathy, a prospective case series. Minerva Endocrinol 38:173\u2013179","journal-title":"Minerva Endocrinol"},{"key":"3054_CR25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10067-008-1040-8","volume":"28","author":"MD Schafranski","year":"2009","unstructured":"Schafranski MD (2009) Idiopathic orbital inflammatory disease successfully treated with rituximab. Clin Rheumatol 28:225\u2013226","journal-title":"Clin Rheumatol"},{"key":"3054_CR26","first-page":"S7","volume":"30","author":"B Baslund","year":"2012","unstructured":"Baslund B, Wiencke AK, Rasmussen N, Faurschou M, Toft PB (2012) Treatment of orbital inflammation with rituximab in Wegner\u2019s granulomatosis. Clin Exp Rheumatol 30:S7\u201310","journal-title":"Clin Exp Rheumatol"},{"key":"3054_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/09273948.2013.863943","volume":"19","author":"RG Abell","year":"2013","unstructured":"Abell RG, Patrick A, Rooney KG, McKelvie PA, McNab AA (2013) Complete resolution of idiopathic sclerosing orbital inflammation after treatment with rituximab. Ocul Immunol Inflamm 19:1\u20134","journal-title":"Ocul Immunol Inflamm"},{"key":"3054_CR28","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ctrv.2005.05.007","volume":"31","author":"E Kimby","year":"2005","unstructured":"Kimby E (2005) Tolerability and safety of Rituximb (MabThera\u00ae). Cancer Treat Rev 31:456\u2013473","journal-title":"Cancer Treat Rev"},{"key":"3054_CR29","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00432-013-1438-9","volume":"139","author":"G Savino","year":"2013","unstructured":"Savino G, Battendieri R, Gari M, Caputo CG, Laurenti L, Blasi MA (2013) Long-term outcomes of primary ocular adnexal lymphoma treatment with intraorbital rituximab injections. J Cancer Res Clin Oncol 139:1251\u20131255","journal-title":"J Cancer Res Clin Oncol"},{"key":"3054_CR30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ophtha.2010.04.036","volume":"118","author":"AJ Ferreri","year":"2011","unstructured":"Ferreri AJ, Govi S, Colucci A, Crocchiolo R, Modorati G (2011) Intralesional Rituximab. A new therapeutic approach for patients with conjunctival lymphomas. Ophthalmology 118:24\u201328","journal-title":"Ophthalmology"},{"key":"3054_CR31","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.ajo.2004.09.032","volume":"138","author":"PA Rubin","year":"2004","unstructured":"Rubin PA, Foster CS (2004) Etiology and management of idiopathic orbital inflammation. Am J Ophthalmol 138:1041\u20131043","journal-title":"Am J Ophthalmol"},{"key":"3054_CR32","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.ijrobp.2009.12.071","volume":"79","author":"C Matthiesen","year":"2011","unstructured":"Matthiesen C, Bogardus C Jr, Thompson JS, Farris B, Hildebrand L, Wilkes B, Syzek E, Algan O, Ahmad S, Herman T (2011) The efficacy of radiotherapy in the treatment of orbital pseudotumor. Int J Radiat Oncol Biol Phys 79:1496\u20131502","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3054_CR33","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ijrobp.2012.06.033","volume":"85","author":"RS Prabhu","year":"2013","unstructured":"Prabhu RS, Kandula S, Liebman L, Wojno TH, Hayek B, Hall WA, Shu HK, Crocker I (2013) Association of clinical response and long-term outcome among patients with biopsied orbital pseudotumor receiving modern radiation therapy. Int J Radiat Oncol Biol Phys 85:643\u2013649","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3054_CR34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/IOP.0b013e31820768f7","volume":"27","author":"EJ Wladis","year":"2011","unstructured":"Wladis EJ, Inglesias BV, Gosselin EJ (2011) Characterization of the molecular biologic milieu of idiopathic orbital inflammation. Ophthal Plast Reconstr Surg 27:251\u2013254","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"3054_CR35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1442-9071.2006.01225.x","volume":"34","author":"L Lim","year":"2006","unstructured":"Lim L, Eb Suhler, Smith JR (2006) Biologic therapies for inflammatory disease. Clin Experiment Ophthalmol 34:365\u2013374","journal-title":"Clin Experiment Ophthalmol"},{"key":"3054_CR36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/01676830903104611","volume":"28","author":"M Salvi","year":"2009","unstructured":"Salvi M, Vannucchi G, Campi I, Beck-Peccoz P (2009) Rituximab in the treatment of thyroid eye disease: science fiction? Orbit 28:251\u2013255","journal-title":"Orbit"},{"key":"3054_CR37","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/archderm.136.3.374","volume":"136","author":"L Heinzerling","year":"2000","unstructured":"Heinzerling L, Dummer R, Kempf W, Schmid MH, Burg G (2000) Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma. Arch Dermatol 136:374\u2013378","journal-title":"Arch Dermatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-014-3054-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-014-3054-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-014-3054-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:21:54Z","timestamp":1559028114000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-014-3054-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,31]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["3054"],"URL":"https:\/\/doi.org\/10.1007\/s00296-014-3054-7","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,31]]}}}